Sold before it exists: the company is already taking committed orders or reservations for output it cannot yet produce
The model's full reasoning — Q4 2021 call → NOWe need to determine if management describes counterparties already committed to take output/product/capacity/service that the company is not yet able to deliver. That is, commitments are real and made, and the ability to supply does not yet fully exist, with the gap being closed now. Let's scan the transcript for any such situation. Key points: The company is SOPHiA GENETICS, a data analytics platform. They discuss growth, customers, partnerships, product launches. - They mention "expecting several signed agreements with Tier 1 institutions in the coming months" - that's prospective, not committed. - They mention "we recently announced onboarding a leading Taiwanese genetic testing company called SOFIVA GENOMICS" - that's a customer onboarding, but is it for a product not yet deliverable? They say "The validation of our solution by this important customer is already underway." So they are validating, but it's a customer using existing solution? They mention "SOFIVA GENOMICS found great success while implementing our solution in a clinical setting for advanced HRD detection" - so they are implementing, so the solution exists. - They mention "we recently announced the partnership with AstraZeneca to expand access to in-house HRD testing across European laboratories and institutions." That's a partnership, but is it a commitment to take output? It's about expanding access, not necessarily a commitment to buy a product not yet built. - They mention "we signed a letter of intent with Ambry Genetics" - a letter of intent is not a firm commitment, it's a preliminary agreement. So that's not a committed order. - They mention "we are currently working together on a new statement of work to begin developing the software infrastructure" with GE - that's development, not a commitment to take output. - They mention "we expect to unveil several exciting new products later this year, one being CarePath" - that's future product, not yet delivered. But do they have commitments for it? They mention "DEEP-Lung-IV study" with sites signed up to participate. That's a clinical study, not a commercial commitment. The study is to validate a model, not to take a product. - They mention "16 sites across six countries have signed up to participate" in the study. That's participation in a study, not a commitment to purchase a product.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GOGO · Q1 2016 → YESThe question is: Does management describe that counterparties have already committed to take output, product, capacity, or service that the company is not yet able to deliver? YES Management describes real commitments (Delta >600, IAG 130+, Shareco 50, Air Canada wide-body fleet, total 2Ku awarded >1000) already made by counterparties. They also state the company is not yet able to deliver at scale ("begin the enviable task of installing the 1000 2Ku awarded aircraft", "we expect to install the majority of our awarded aircraft by the end of 2018", "STCs... will keep us on track to exceed our 75 2Ku installation target this year", "supply chain is there", "aggressive STC program...
SYM · Q3 2022 → YESThe question is: Does management describe that counterparties have already committed to take output that the company is not yet able to deliver? Like a backlog of things they haven't built yet. YES The transcript shows management describing a $11.3 billion contracted revenue backlog (more than doubled) with customers having "voted with their wallets," alongside 13 systems currently in deployment (plus 6 fully ramped) that will take roughly 18 months to acceptance.
BXP · Q1 2022 → YESThe question is about whether management describes counterparties that have already committed to take output that the company is not yet able to deliver, like pre-leased developments that aren't built...YES The transcript shows multiple instances where management describes counterparties having already signed leases for space in developments that have not yet been completed or even commenced construction.